Literature DB >> 19509187

Glucagon acts in a dominant manner to repress insulin-induced mammalian target of rapamycin complex 1 signaling in perfused rat liver.

Jamie I Baum1, Scot R Kimball, Leonard S Jefferson.   

Abstract

The opposing actions of insulin and glucagon on hepatic carbohydrate metabolism are well documented. In contrast, relatively little is known about how the two hormones interact to regulate hepatic protein metabolism. Previously, we reported that glucagon in the absence of insulin represses signaling through the mammalian target of rapamycin complex 1 (mTORC1). In the present study, we sought to determine whether or not the action of one hormone would dominate over the other in the regulation of mTORC1 signaling. Livers were perfused in situ with medium containing either no added hormones (control), 10 nM insulin, 100 nM glucagon, or a combination of the hormones. Compared with control livers, insulin stimulated Akt phosphorylation and mTORC1 signaling, as assessed by increased phosphorylation of the mTORC1 targets eIF4E-binding protein (4E-BP)1 and ribosomal protein S6 kinase (S6K)1, and promoted assembly of the eIF4G x eIF4E complex. Glucagon alone had no effect on mTORC1 signaling but stimulated the activity of protein kinase A (PKA). In the presence of a combination of insulin and glucagon, Akt and TSC2 phosphorylation and PKA activity were all increased compared with controls. However, mTORC1 signaling was repressed compared with livers perfused with medium containing insulin alone, and this effect was associated with reduced assembly of the mTORC1 x eIF3 complex. Overall, the results suggest that glucagon acts in a dominant manner to repress insulin-induced mTORC1 signaling, which is in contrast to previous studies showing a dominant action of insulin in the control of hepatic gluconeogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19509187      PMCID: PMC2724106          DOI: 10.1152/ajpendo.00042.2009

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  35 in total

1.  The perfused rat liver.

Authors:  J H Exton
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

2.  Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling.

Authors:  Ken Inoki; Yong Li; Tian Xu; Kun-Liang Guan
Journal:  Genes Dev       Date:  2003-07-17       Impact factor: 11.361

Review 3.  Insulin regulation of PEPCK gene expression: a model for rapid and reversible modulation.

Authors:  P G Quinn; D Yeagley
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2005-12

4.  A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.

Authors:  A Sekulić; C C Hudson; J L Homme; P Yin; D M Otterness; L M Karnitz; R T Abraham
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

5.  Rheb binds and regulates the mTOR kinase.

Authors:  Xiaomeng Long; Yenshou Lin; Sara Ortiz-Vega; Kazuyoshi Yonezawa; Joseph Avruch
Journal:  Curr Biol       Date:  2005-04-26       Impact factor: 10.834

6.  Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency.

Authors:  Xiaomeng Long; Sara Ortiz-Vega; Yenshou Lin; Joseph Avruch
Journal:  J Biol Chem       Date:  2005-05-05       Impact factor: 5.157

7.  Regulation of insulin signalling by hyperinsulinaemia: role of IRS-1/2 serine phosphorylation and the mTOR/p70 S6K pathway.

Authors:  M Ueno; J B C Carvalheira; R C Tambascia; R M N Bezerra; M E Amaral; E M Carneiro; F Folli; K G Franchini; M J A Saad
Journal:  Diabetologia       Date:  2005-02-04       Impact factor: 10.122

8.  Plasma glucagon and insulin responses depend on the rate of appearance of amino acids after ingestion of different protein solutions in humans.

Authors:  Jose A L Calbet; Dave A MacLean
Journal:  J Nutr       Date:  2002-08       Impact factor: 4.798

9.  TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling.

Authors:  Ken Inoki; Yong Li; Tianquan Zhu; Jun Wu; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

10.  Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive.

Authors:  Estela Jacinto; Robbie Loewith; Anja Schmidt; Shuo Lin; Markus A Rüegg; Alan Hall; Michael N Hall
Journal:  Nat Cell Biol       Date:  2004-10-03       Impact factor: 28.824

View more
  16 in total

1.  Glucagon's effect on liver protein metabolism in vivo.

Authors:  Guillaume Kraft; Katie C Coate; Jason J Winnick; Dominique Dardevet; E Patrick Donahue; Alan D Cherrington; Phillip E Williams; Mary Courtney Moore
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-05-23       Impact factor: 4.310

2.  Phosphatidic acid mediates activation of mTORC1 through the ERK signaling pathway.

Authors:  Jeremiah N Winter; Todd E Fox; Mark Kester; Leonard S Jefferson; Scot R Kimball
Journal:  Am J Physiol Cell Physiol       Date:  2010-04-28       Impact factor: 4.249

3.  Differential contribution of insulin and amino acids to the mTORC1-autophagy pathway in the liver and muscle.

Authors:  Takako Naito; Akiko Kuma; Noboru Mizushima
Journal:  J Biol Chem       Date:  2013-06-06       Impact factor: 5.157

4.  Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis.

Authors:  Shijie Li; Michael S Brown; Joseph L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

5.  Leucine supplementation stimulates protein synthesis and reduces degradation signal activation in muscle of newborn pigs during acute endotoxemia.

Authors:  Adriana D Hernandez-García; Daniel A Columbus; Rodrigo Manjarín; Hanh V Nguyen; Agus Suryawan; Renán A Orellana; Teresa A Davis
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-09-13       Impact factor: 4.310

6.  Leucine supplementation at the onset of high-fat feeding does not prevent weight gain or improve glycemic regulation in male Sprague-Dawley rats.

Authors:  Jamie I Baum; Tyrone A Washington; Stephanie A Shouse; Walter Bottje; Sami Dridi; Gina Davis; Dameon Smith
Journal:  J Physiol Biochem       Date:  2016-08-20       Impact factor: 4.158

7.  Consumption of a high fat diet promotes protein O-GlcNAcylation in mouse retina via NR4A1-dependent GFAT2 expression.

Authors:  Weiwei Dai; Sadie K Dierschke; Allyson L Toro; Michael D Dennis
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-11       Impact factor: 5.187

Review 8.  Emerging role of AMP-activated protein kinase in endocrine control of metabolism in the liver.

Authors:  Clinton M Hasenour; Eric D Berglund; David H Wasserman
Journal:  Mol Cell Endocrinol       Date:  2012-07-14       Impact factor: 4.102

9.  cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity.

Authors:  Jianling Xie; Godwin A Ponuwei; Claire E Moore; Gary B Willars; Andrew R Tee; Terence P Herbert
Journal:  Cell Signal       Date:  2011-07-06       Impact factor: 4.315

10.  Glucagon transiently stimulates mTORC1 by activation of an EPAC/Rap1 signaling axis.

Authors:  Siddharth Sunilkumar; Scot R Kimball; Michael D Dennis
Journal:  Cell Signal       Date:  2021-04-17       Impact factor: 4.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.